Schering-Plough Clarinex Gains Indication Parity With Pfizer’s Zyrtec

Schering-Plough's Clarinex will carry the same range of indications as Pfizer's Zyrtec following the approval of desloratadine for perennial allergic rhinitis and chronic idiopathic urticaria